Brief Research Report
Published on 14 Mar 2025
OligoDOMTM: a T-cell response-enhancing platform applied to cancer immunotherapy
in Vaccines and Molecular Therapeutics
- 1,613 views
Brief Research Report
Published on 14 Mar 2025
in Vaccines and Molecular Therapeutics
Review
Published on 14 Mar 2025
in Vaccines and Molecular Therapeutics
Original Research
Published on 14 Mar 2025
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 14 Mar 2025
in Viral Immunology
Hypothesis and Theory
Published on 14 Mar 2025
in Immunological Tolerance and Regulation
Brief Research Report
Published on 14 Mar 2025
in T Cell Biology
Original Research
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy
Case Report
Published on 14 Mar 2025
in Alloimmunity and Transplantation
Original Research
Published on 14 Mar 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy
Original Research
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy
Review
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy
Case Report
Published on 14 Mar 2025
in Multiple Sclerosis and Neuroimmunology
Systematic Review
Published on 14 Mar 2025
in Cancer Immunity and Immunotherapy